相关实验视频

Updated: Jun 28, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

血卡利克林支持在小鼠全血中独立于FXII的血栓生成

Jun Wan^1,2,3, Sophia Dhrolia^1,2, Rohan R Kasthuri^1,2

¹UNC Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.

|April 9, 2024

概括

血卡利克林 (PKa) 通过接触途径在小鼠全血中显著促进血栓生成. 这一活动的一部分独立于XII因子 (FXII),突出显示PKaKa.

科学领域:

凝血生物学凝血生物学
血液静止研究血液静止研究
血栓生成测定试验血栓生成测定试验

背景情况:

血卡利克林 (PKa) 在凝血过程中激活XII因子 (FXII).
此外,PKa也可以独立于FXII激活因子IX (FIX),从而促进前凝性活性.

研究的目的:

在小鼠全血血栓生成试验中评估PKa的前凝活性.
研究PKa在FXII依赖性和FXII独立性凝血路径中的作用.

主要方法:

使用小鼠全血血生成试验.
雇佣了缺乏PKa的小鼠和缺乏FXII的小鼠.
使用小分子和抗体抑制剂向PKa和FXIIa.

主要成果:

与野生型相比,缺乏PKa的全血显示出接触途径启动的血栓生成减少.
在缺乏FXII的血液中,PKa阻塞显著降低了血栓生成,这表明PKa功能独立于FXII.
在缺乏PKa的血液中,FXIIa抑制减少了血栓的生成,这表明FXIIa独立于PKa的功能.

结论:

在小鼠全血中,PKa在接触途径介导的血栓生成中发挥着重要作用.
部分PKa的促凝活性是独立于FXII的,通过直接FIX激活或其他途径进行介导.

更多相关视频

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

相关概念视频

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...